182 related articles for article (PubMed ID: 30245591)
1. DNA methylation biomarkers for hepatocellular carcinoma.
Fan G; Tu Y; Chen C; Sun H; Wan C; Cai X
Cancer Cell Int; 2018; 18():140. PubMed ID: 30245591
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
Sang L; Wang XM; Xu DY; Zhao WJ
World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
[TBL] [Abstract][Full Text] [Related]
3. Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma.
Cai C; Wang W; Tu Z
J Cancer; 2019; 10(2):355-366. PubMed ID: 30719129
[No Abstract] [Full Text] [Related]
4. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
5. Using Integrated Bioinformatics Analysis to Identify Abnormally Methylated Differentially Expressed Genes in Hepatocellular Carcinoma.
Chen QL; Yan Q; Feng KL; Xie CF; Fang CK; Wang JN; Liu LH; Li Y; Zhong C
Int J Gen Med; 2021; 14():805-823. PubMed ID: 33732011
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
[TBL] [Abstract][Full Text] [Related]
7. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
Tu Y; Fan G; Xi H; Zeng T; Sun H; Cai X; Kong W
J Cell Biochem; 2018 Nov; 119(11):8797-8806. PubMed ID: 30069928
[TBL] [Abstract][Full Text] [Related]
8. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
9. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
Yang WX; Pan YY; You CG
Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
11. Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer.
Qi L; Zhou B; Chen J; Hu W; Bai R; Ye C; Weng X; Zheng S
J Cancer; 2019; 10(26):6618-6634. PubMed ID: 31777591
[No Abstract] [Full Text] [Related]
12. Aberrantly methylated-differentially expressed genes and pathways in colorectal cancer.
Liu J; Li H; Sun L; Wang Z; Xing C; Yuan Y
Cancer Cell Int; 2017; 17():75. PubMed ID: 28794688
[TBL] [Abstract][Full Text] [Related]
13. Combined screening analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
Cao J; Zhang R; Zhang Y; Wang Y
J Gastrointest Oncol; 2022 Feb; 13(1):311-325. PubMed ID: 35284134
[TBL] [Abstract][Full Text] [Related]
14. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
Yi L; Luo P; Zhang J
J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
[TBL] [Abstract][Full Text] [Related]
15. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
16. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis.
Mi N; Cao J; Zhang J; Fu W; Huang C; Gao L; Yue P; Bai B; Lin Y; Meng W; Li X
Oncol Lett; 2020 Aug; 20(2):1695-1708. PubMed ID: 32724412
[TBL] [Abstract][Full Text] [Related]
17. Identification of hub genes and biological pathways in hepatocellular carcinoma by integrated bioinformatics analysis.
Zhao Q; Zhang Y; Shao S; Sun Y; Lin Z
PeerJ; 2021; 9():e10594. PubMed ID: 33552715
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients.
Zhuang L; Yang Z; Meng Z
Biomed Res Int; 2018; 2018():7897346. PubMed ID: 30363964
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma.
Zhen L; Ning G; Wu L; Zheng Y; Yang F; Chen T; Xu W; Liu Y; Xie C; Peng L
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32955083
[TBL] [Abstract][Full Text] [Related]
20. Identification of aberrantly methylated differentially expressed genes in prostate carcinoma using integrated bioinformatics.
Wu K; Yin X; Jin Y; Liu F; Gao J
Cancer Cell Int; 2019; 19():51. PubMed ID: 30872976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
